Tenders/Invitation to Submit Proposals under Framework Agreement(s) 2023/304 - Group 4 Medications: Blood; 2023/436 - Medications for the Central Nervous System; 2023/437 - Antiallergic Medications, Vitamins and Minerals, and Medications Used in the Treatment of Poisoning; 2023/490 - Medications Used for Skin Conditions; 2023/491 - Oncological Medications and Immunomodulators; 2023/492 - Antiinfective Medications; 2024/1077 - Various Medications (II); 2024/780 - Medications
Awarded🇵🇹PortugalSupplies

Invitation to Submit Proposals under Framework Agreement(s) 2023/304 - Group 4 Medications: Blood; 2023/436 - Medications for the Central Nervous System; 2023/437 - Antiallergic Medications, Vitamins and Minerals, and Medications Used in the Treatment of Poisoning; 2023/490 - Medications Used for Skin Conditions; 2023/491 - Oncological Medications and Immunomodulators; 2023/492 - Antiinfective Medications; 2024/1077 - Various Medications (II); 2024/780 - Medications

Auto-translated from Portuguese
Original title: Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2023/304 - Medicamentos do grupo 4: sangue; 2023/436 - Medicamentos para o sistema nervoso central; 2023/437 - Medicação antialérgica, vitaminas e sais minerais e medicamentos usados no tratamento de intoxicações; 2023/490 - Medicamentos usados em afeções cutâneas; 2023/491 - Medicamentos do foro oncológico e imunomoduladores; 2023/492 - Medicamentos anti-infeciosos; 2024/1077 - Medicamentos diversos (II); 2024/780 - Medicament
Unidade Local de Saúde Tâmega e Sousa, E.P.E.
Published: Feb 12, 2026
Updated: Jun 19, 2026
Source: Portal BASE (Portugal)

About This Opportunity

Translated

This tender invites proposals for the procurement of various groups of medications under multiple framework agreements for the years 2023 and 2024. The specific categories include medications for blood, the central nervous system, antiallergic treatments, vitamins and minerals, treatments for poisoning, skin conditions, oncological treatments, immunomodulators, and antiinfective medications. The tender aims to ensure a reliable supply of essential pharmaceuticals to meet healthcare needs. Key requirements for bidders may include compliance with regulatory standards, quality assurance protocols, and the ability to deliver medications within specified timelines. Interested parties are expected to demonstrate their capacity to fulfill the procurement needs outlined in the tender documents. The location of the procurement is not specified, but it is implied that the medications will be used within a healthcare framework that adheres to national or regional health policies. This tender represents an important opportunity for pharmaceutical suppliers to engage in public procurement and contribute to the healthcare sector's capacity to provide necessary treatments.

This is a supplies contract in the information and communication technology sector. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 4,480.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the information and communication technology sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Original language: Portuguese

The tender titled "Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2023/304 - Medicamentos do grupo 4: sangue; 2023/436 - Medicamentos para o sistema nervoso central; 2023/437 - Medicação antialérg" is issued in Portugal, under the jurisdiction of public procurement regulations.

This invitation seeks proposals for the supply of various pharmaceutical products, specifically focusing on blood-related medications, central nervous system drugs, and anti-allergic medications.

The contracting authority, while not explicitly named in the available information, is expected to be a public health organization or governmental body responsible for pharmaceutical procurement in Portugal. The tender is part of a framework agreement aimed at establishing long-term partnerships with suppliers to ensure the timely delivery of essential medications to healthcare facilities across the country.

Potential bidders should be prepared to demonstrate their compliance with relevant regulatory and quality standards, including certifications for pharmaceutical manufacturing and distribution. Typical requirements for such tenders include proof of previous experience in supplying similar medications, the ability to meet specific delivery timelines, and adherence to safety and efficacy standards as stipulated by health authorities.

Bidders must also present competitive pricing structures, ensuring that the proposed costs align with budgetary constraints while maintaining the quality of the medications offered. This tender represents a significant opportunity for pharmaceutical companies looking to expand their presence in the Portuguese healthcare market while contributing to the provision of critical medical supplies.

Data provenance

This notice is sourced from base_gov_pt and was originally published on February 12, 2026. Last refreshed 6 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Unidade Local de Saúde Tâmega e Sousa, E.P.E.

Unidade Local de Saúde Tâmega e Sousa, E.P.E. has issued 386 procurement notices on BidsFactory, including 2 currently open and 334 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to Novo Nordisk Portugal, Lda.. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Unidade Local de Saúde Tâmega e Sousa, E.P.E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Information & Communication Technology sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

What is the estimated budget?

The estimated contract value is Up to €4,480. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.

Where will the contract be performed?

The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

Find tenders like this automatically

Set up alerts and filters that match your business — never miss a relevant opportunity again.

See plans

Key Details

Estimated Budget
Up to €4,480
Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
Portuguese

Contracting Authority

Unidade Local de Saúde Tâmega e Sousa, E.P.E.
🇵🇹Portugal

Matching Experts

Are you a consultant?

Join our Expert Network and get matched with relevant tenders.